Maze Therapeutics Announces Positive Phase 1 Data for MZE829 in Treating APOL1 Kidney Disease
Maze Therapeutics, a clinical-stage biopharmaceutical company focused on leveraging human genetics to create innovative small molecule precision medicines for common diseases, has announced promising results from the Phase 1 clinical…
BioHub Maryland Launches Biopharma Workforce Training Center in Montgomery County’s Life Sciences Corridor
BioHub Maryland, an initiative aimed at accelerating the life sciences sector in the state, officially opened its new biopharmaceutical workforce training center on October 24 at 9808 Medical Center Drive…
Evecxia Therapeutics Successfully Completes Pre-IND Meeting with FDA on EVX-101 Development for Depression
Evecxia Therapeutics has announced the successful completion of a pre-Investigational New Drug (pre-IND) meeting with the U.S. Food and Drug Administration (FDA) Division of Psychiatry, Office of Neuroscience, Center for…
Lilly’s EBGLYSS™ Achieves Skin Clearance and Itch Relief in Atopic Dermatitis Patients
Eli Lilly and Company has reported encouraging findings regarding its treatment EBGLYSS, showing significant improvements in skin condition and itch relief for patients suffering from moderate-to-severe atopic dermatitis (eczema) who…
Vertex Provides Kidney Program Updates at ASN Kidney Week Congress
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced updates on its kidney disease pipeline, which includes treatments for IgA nephropathy (IgAN), primary membranous nephropathy (pMN), and APOL1-mediated kidney disease (AMKD). These updates…
Every Day Without Vision Is One Too Many: Tackling the Impact of Eye Diseases
Losing your sight can profoundly impact your life, affecting everything from connections to experiences. Our eyes serve as a window to the world, and when vision is lost, it can…
Walgreens Prescription Delivery: Everything You Need to Know
Walgreens understands that health needs can arise anytime, and sometimes it’s more convenient to have essentials brought directly to you. As a pharmacy-first company, Walgreens has been offering prescription delivery…
Inaugural Meeting of the Acute Care Action Network
The World Health Organization (WHO) held the first meeting of the Acute Care Action Network (ACAN) on October 17–18 in Geneva, Switzerland, bringing together key stakeholders to strengthen global acute…
Revolution Medicines Reports Initial Data on RMC-9805 Monotherapy in Advanced Pancreatic Cancer
Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company specializing in targeted therapies for RAS-driven cancers, has announced promising early data on RMC-9805, a selective inhibitor for the RAS(ON) G12D…
D.A. Davidson Guides Allivet, Inc. in Its Upcoming Sale to Tractor Supply Company
D.A. Davidson has announced its role as the exclusive sell-side financial advisor to Allivet, Inc., an online pet pharmacy specializing in medications, supplements, and various pet products, regarding its upcoming…
GenSight Biologics Provides Business Update and Cash Position as of September 30, 2024
GenSight Biologics Reports €3.4 Million Cash Position as of September 30, 2024, and Business Update GenSight Biologics (“GenSight” or the “Company”) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharmaceutical company…
Merz Therapeutics and World Stroke Organization Launch Initiative to Enhance Stroke Treatment in Africa
Launch of Access to Health Initiative Announced at World Stroke Congress The World Stroke Organization (WSO) President, Dr. Sheila Martins, officially launched the Access to Health initiative at the annual…